Abstract
We analysed the evolution of different cytokines (IL-4, IL-6, tumour necrosis factor alpha and vascular endothelial growth factor; VEGF) involved in the development of Kaposi's sarcoma in two patients in whom HIV infection presented with disseminated Mycobacterium tuberculosis infection. They simultaneously developed tuberculosis-associated immune restoration disease and Kaposi's sarcoma shortly after the initiation of HAART. Analysis of VEGF and pro-inflammatory cytokines led us to hypothesize that Kaposi's sarcoma could be promoted by the tuberculosis immune response.
MeSH terms
-
Adult
-
Antiretroviral Therapy, Highly Active
-
Cytokines / blood*
-
Female
-
Gastrointestinal Neoplasms / blood
-
Gastrointestinal Neoplasms / complications
-
Gastrointestinal Neoplasms / immunology
-
HIV Infections / blood
-
HIV Infections / complications
-
HIV Infections / immunology*
-
Humans
-
Interleukin-4 / blood
-
Interleukin-6 / blood
-
Respiratory Tract Neoplasms / blood
-
Respiratory Tract Neoplasms / complications
-
Respiratory Tract Neoplasms / immunology
-
Sarcoma, Kaposi / blood
-
Sarcoma, Kaposi / complications
-
Sarcoma, Kaposi / immunology*
-
Skin Neoplasms / blood
-
Skin Neoplasms / complications
-
Skin Neoplasms / immunology
-
Tuberculosis / blood
-
Tuberculosis / complications
-
Tuberculosis / immunology*
-
Tumor Necrosis Factor-alpha / blood
-
Vascular Endothelial Growth Factor A / blood
Substances
-
Cytokines
-
Interleukin-6
-
Tumor Necrosis Factor-alpha
-
Vascular Endothelial Growth Factor A
-
Interleukin-4